FAABORG PHARMA A/S: Financial statements 2022
CVR: 26190770
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
FAABORG PHARMA A/S (CVR 26190770) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,327,505 and a net result of DKK 1,558,886 compared with DKK 31,438 the year before. That is an increase of 48% compared with the year before. Equity in the 2022 report amounted to DKK 6,383,237. The solvency ratio was 34.8%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 10,327,505
- Profit/Loss
- DKK 1,558,886
- Equity
- DKK 6,383,237
- Total Assets
- DKK 18,316,615
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 10.3 mio. | 1.6 mio. | 6.4 mio. | 17 |
| 2021 | - | 7 mio. | 31 t. | 4.8 mio. | 15 |
| 2020 | - | 11.3 mio. | 4 mio. | 4.8 mio. | 11 |
| 2019 | - | 6.5 mio. | 713 t. | 801 t. | 11 |
| 2018 | - | 6.8 mio. | 2.1 mio. | 88 t. | 9 |
Official annual report
Keep an eye on FAABORG PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 15, 2022, Faaborg Løve Produkter Holding I ApS is registered as an owner of FAABORG PHARMA A/S with an ownership share of 100%.
As of December 1, 2022, Frank Hauken Vibæk is registered as director of FAABORG PHARMA A/S.
As of December 1, 2022, Sten Grønved Nielsen has stepped down as director of FAABORG PHARMA A/S.
As of October 21, 2022, Birk Simon Maldonado Andersen has joined the board of directors of FAABORG PHARMA A/S.
As of October 21, 2022, Sten Grønved Nielsen has left the board of directors of FAABORG PHARMA A/S.
As of October 21, 2022, Pernille Rosager Nielsen has left the board of directors of FAABORG PHARMA A/S.
On March 30, 2022, the company changed its name from FAABORG PHARMA ApS to FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 6,979,843, and the net result was DKK 31,438.
About FAABORG PHARMA A/S
FAABORG PHARMA A/S is a Danish company of the type Aktieselskab based in Faaborg, founded in 2001. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named FAABORG PHARMA ApS and FAABORG LØVE PRODUKTER ApS. The management consists of Frank Hauken Vibæk. The board consists of Claus Wædeled (chair), Birk Simon Maldonado Andersen and Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 13,336,305 and a net result of DKK 747,032 compared with DKK 1,762,826 the year before. Equity in the 2025 report amounted to DKK 10,503,744.